Author:
Shoji Sunao,Ukimura Osamu,de Castro Abreu Andre Luis,Marien Arnaud,Matsugasumi Toru,Bahn Duke,Gill Inderbir S.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. NCCN Guidelines™ Version 4 (2013) National Comprehensive Cancer Network, Inc, Washington
2. Klotz L (2005) Active surveillance for prostate cancer: for whom? J Clin Oncol 23:8165–8169. doi: 10.1200/JCO.2005.03.3134
3. Soloway MS, Soloway CT, Williams S, Ayyathurai R, Kava B, Manoharan M (2008) Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience. BJU Int 101:165–169. doi: 10.1111/j.1464-410X.2007.07190.x
4. van den Bergh RC, Roemeling S, Roobol MJ, Aus G, Hugosson J, Rannikko AS, Tammela TL, Bangma CH, Schroder FH (2009) Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly. Eur Urol 55:1–8. doi: 10.1016/j.eururo.2008.09.007
5. Network NCC: prostate cancer guideline v1 (2009). http://www.nccn.org
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献